(1)
Bellone, M.; Pradelli, L.; Tavarozzi, R.; Ladetto, M.; Nepoti, G.; Guardalben, E.; Ghislieri, D. Economic Consequences of Administering Obinutuzumab As a Short Duration Infusion in Italian Patients With Advanced Follicular Lymphoma: A Cost Analysis. FE 2022, 23.